Citigroup Inc.
C
$115.25
-0.04%
Citigroup Inc. is a global financial-services company operating primarily in the Banks - Diversified industry. It is a major international bank with a presence in over 160 countries, defined by its extensive cross-border banking network and diversified operations across services, markets, and personal banking.…
C
Citigroup Inc.
$115.25
Related headlines
Investment Opinion: Should I buy C Today?
Based on a synthesis of the technical, fundamental, and valuation data, the objective assessment for Citigroup (C) is a Hold. The stock's compelling valuation (low forward P/E, P/B ~1) and strong relative momentum are positive. However, these are counterbalanced by severe fundamental red flags, most notably the massive negative free cash flow and elevated financial leverage. For existing shareholders, the valuation provides some downside protection, but the significant risks currently outweigh the catalysts for new capital allocation, suggesting investors should wait for clearer signs of improved financial health before establishing new positions.
Sign up to view all
C 12-Month Price Forecast
The analysis yields a neutral stance with medium confidence. The valuation is undeniably cheap, and momentum has been strong, but the fundamental financial health of the company, as evidenced by the FCF and leverage, presents risks that are too substantial to ignore. The base case of sideways action seems most probable as these opposing forces play out.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Citigroup Inc.'s 12-month outlook, with a consensus price target around $149.83 and implied upside of +30.0% versus the current price.
Average Target
$149.83
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$92 - $150
Analyst target range
No sufficient analyst coverage available.
Bulls vs Bears: C Investment Factors
Citigroup presents a mixed picture. Bullish arguments center on its strong relative performance, attractive forward valuation, and global footprint. However, significant bearish concerns exist, including alarming negative free cash flow, high leverage, and recent margin contraction. The stock's position near its 52-week high adds to near-term caution.
Bullish
- Strong Relative Performance: Outperformed S&P 500 significantly over 1-month, 6-month, and 1-year periods.
- Attractive Forward Valuation: Forward P/E of 9.34 is low, suggesting potential for multiple expansion.
- Trading Near Book Value: P/B ratio of ~1.00 indicates the stock is not overvalued on an asset basis.
- Global Diversified Network: Presence in over 160 countries provides a stable, diversified revenue base.
Bearish
- Negative Free Cash Flow: Trailing twelve-month FCF is -$97.04B, a major red flag for financial flexibility.
- High Debt and Low Liquidity: Debt-to-equity of 3.37 is elevated; current ratio of 0.48 signals liquidity risk.
- Revenue and Margin Pressure: Q4 revenue declined YoY; net margin contracted sequentially from Q3.
- Trading Near 52-Week High: Price at ~90.6% of yearly high may limit near-term upside potential.
C Technical Analysis
The stock has demonstrated significant strength over the observed 180-day period, rising from around $97 in early October 2025 to a closing price of $113.41 on March 31, 2026. This represents an overall uptrend, though the price has experienced notable volatility with peaks near $124 in January 2026 and subsequent pullbacks. Over the short term, the stock gained 2.92% in the past month and declined 2.81% over the past three months, significantly outperforming the S&P 500 which fell 5.25% and 4.63% over the same periods, respectively. The current price of $113.41 sits near the upper end of its 52-week range of $55.51 to $125.16, indicating the stock is trading at approximately 90.6% of its yearly high.
Beta
1.13
1.13x market volatility
Max Drawdown
-27.3%
Largest decline past year
52-Week Range
$56-$125
Price range past year
Annual Return
+60.6%
Cumulative gain past year
| Period | C Return | S&P 500 |
|---|---|---|
| 1m | +4.1% | -3.6% |
| 3m | -2.9% | -4.0% |
| 6m | +17.9% | -2.0% |
| 1y | +60.6% | +16.2% |
| ytd | -2.9% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
C Fundamental Analysis
Revenue in Q4 2025 was $40.86B, showing a slight year-over-year decline of 0.11% from Q4 2024. Profitability metrics have been mixed; the Q4 2025 net income was $2.43B with a net margin of 5.96%, which is lower than the Q3 2025 net margin of 8.56%, indicating a sequential contraction. The company's financial health shows a high debt-to-equity ratio of 3.37, which is elevated, and a current ratio of 0.48, suggesting potential liquidity constraints. Operating cash flow was positive at $3.67B in Q4 2025, but the trailing twelve-month free cash flow is a substantial negative $97.04B, a point of concern. Operational efficiency, as measured by Return on Equity (ROE), was 6.72%, which is relatively modest.
Quarterly Revenue
$40.9B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.43%
Latest Quarter
Free Cash Flow
$-97.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is C Overvalued?
Given the company's positive net income, the primary valuation metric used is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is 14.89, while the forward P/E is lower at 9.34, suggesting expectations of earnings growth. The Price-to-Sales (P/S) ratio is 1.26, and the Price-to-Book (P/B) ratio is approximately 1.00, indicating the stock is trading close to its book value. Peer comparison data for industry averages is not available in the provided inputs.
PE
14.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -13x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.1x
Enterprise Value Multiple
Investment Risk Disclosure
Citigroup faces several material risks. Financially, the company's negative $97 billion trailing twelve-month free cash flow is a severe concern, indicating potential strain on capital allocation and dividend sustainability. The high debt-to-equity ratio of 3.37 and a weak current ratio of 0.48 compound liquidity and solvency risks, making the bank vulnerable in a rising interest rate or economic downturn scenario.
Operationally, the bank is exposed to global macroeconomic and geopolitical volatility, as evidenced by news referencing disruptions from US-Iran tensions. Furthermore, political pressure on credit card issuers and regulatory scrutiny present ongoing headwinds for its US personal banking segment. The sequential decline in net margin from Q3 to Q4 2025 suggests operational efficiency challenges that could persist.
Market-wise, while the stock has shown strong relative strength, its price near the 52-week high ($113.41 vs. $125.16 high) increases vulnerability to a pullback, especially if the broader market weakens further. The bank's profitability metrics, such as a modest ROE of 6.72%, lag behind what might be expected for a firm carrying such financial risk.
FAQ
The primary risks are financial. The massive negative free cash flow (-$97B TTM) threatens dividend sustainability and strategic flexibility. High financial leverage (Debt/Equity of 3.37) and poor liquidity (Current Ratio of 0.48) increase vulnerability in a downturn. Operationally, revenue growth is stagnant, and net margins are contracting. Externally, the bank is exposed to global geopolitical tensions and regulatory pressures, particularly in its US card business.
The 12-month outlook is mixed with a base case target range of $105 to $120, representing modest upside from the current ~$113. This assumes the company manages its challenges without a major crisis, supported by analyst EPS expectations averaging $17.6. The bull case (25% probability) sees a re-test of the $125+ highs on successful execution, while the bear case (20% probability) could see a drop toward $85-$100 if macro conditions worsen and financial risks materialize.
C appears statistically undervalued based on traditional multiples. Its forward P/E ratio of 9.34 is low, and it trades at approximately its book value (P/B ~1.00). However, this apparent undervaluation is likely a reflection of the market pricing in significant risks, namely the catastrophic negative free cash flow and high leverage. Therefore, it may be more accurately described as a 'value trap' rather than a clear-cut undervalued opportunity.
Based on current data, C is not a compelling buy for most investors. While its forward P/E of 9.34 and P/B ratio of 1.00 appear cheap, these are offset by severe fundamental issues, including a negative $97 billion trailing free cash flow and a high debt-to-equity ratio of 3.37. The stock has had a strong run, trading near its 52-week high, which limits near-term upside. A 'Hold' rating is more appropriate until there is evidence of improved financial health.
C is not suitable for short-term trading due to its volatility and lack of near-term catalysts. For a long-term horizon, it carries high speculative risk; an investor must have strong conviction that management can execute a multi-year turnaround to fix the cash flow and leverage problems. Given the magnitude of these issues, it is a high-risk, potentially high-reward long-term bet rather than a core, stable holding for a retirement portfolio.